Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Urokinase-streptokinase embolism trial. Phase 2 results. A cooperative study.

× No keyword cloud information.

38 in total

1. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors: Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal: Chest Date: 2012-02 Impact factor: 9.410

2. Venous thromboembolic disease: the use of "optional" inferior vena cava filters.

Authors: Anthony C Venbrux; Elizabeth A Ignacio; Shawn N Sarin; Amy P Soltes; Noel C Haskins; Dmitri Gagarin
Journal: Semin Intervent Radiol Date: 2008-03 Impact factor: 1.513

Review 3. The role of thrombolytic therapy in pulmonary embolism.

Authors: Tzu-Fei Wang; Alessandro Squizzato; Francesco Dentali; Walter Ageno
Journal: Blood Date: 2015-01-28 Impact factor: 22.113

4. Elastase digested urokinase (ED-UK).

Authors: H Sumi; T Kosugi; N Toki; H Mihara
Journal: Experientia Date: 1985-12-15

Review 5. Pulmonary hypertension.

Authors: J R Michael; W R Summer
Journal: Lung Date: 1985 Impact factor: 2.584

Review 6. Deep vein thrombosis and pulmonary embolism: clinical presentation and pathophysiologic consequences.

Authors: A J Comerota
Journal: Cardiovasc Intervent Radiol Date: 1988 Impact factor: 2.740

7. [Fibrinolytic therapy of lower limb deep vein thrombosis with urokinase (author's transl)].

Authors: R Zimmermann; J Harenberg; H Mörl; H M Kuhn; P Wahl; P Gerhardt
Journal: Klin Wochenschr Date: 1982-05-17

Review 8. [Errors and risks in perioperative thrombolysis therapy].

Authors: F Spöhr; B W Böttiger; A Walther
Journal: Anaesthesist Date: 2005-05 Impact factor: 1.041

9. Improving adjunctive treatment in pulmonary embolism and fibrinolytic therapy. The role of enoxaparin and weight-adjusted unfractionated heparin.

Authors: Carlos Jerjes-Sánchez; Sergio Villarreal-Umaña; Alicia Ramírez-Rivera; Anabel Garcia-Sosa; Luis Miguel-Canseco; Tamara Archondo; Esteban Reyes; Angel Garza; Roberto Arriaga; Francisco Castillo; Omar Jasso; Hector Garcia; Martha Bermudez; Jose Maria Hernandez; Jorge Garcia; Pedro Martinez; Francisco Rangel; Jorge Gutierrez; Alfredo Comparan-Nuñez
Journal: J Thromb Thrombolysis Date: 2008-01-19 Impact factor: 2.300

Review 10. Antithrombotic drugs: part II.

Authors: A S Gallus; J Hirsh
Journal: Drugs Date: 1976 Impact factor: 9.546